About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

MISA to NRDS：a Multicenter Study in China | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04077333

MISA to NRDS：a Multicenter Study in China

BACKGROUND Treatment of neonatal respiratory distress syndrome with exogenous surfactant and mechanical ventilation made millions of preterm infants survived in neonatal intensive care unit (NICU). En...

Lead sponsor: Peking University Third Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Peking University Third Hospital

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. preterm infants born before 32 weeks gestational age
•2. spontaneously breathing receiving continuous positive airway pressure (CPAP) or NIPPV (Non-invasive positive pressure ventilation) without intubation
•3. clinical diagnosis of respiratory distress syndrome.

Exclusion Criteria

•1. with obvious malformations
•2. with asphyxia requiring intubation during resuscitation
•3. need endotracheal intubation or mechanical ventilation before surfactant administration.

Related studies

PDA for Kidneys Study

NCT06658496 · Patent Ductus Arteriosus, Congenital Heart Disease

RECRUITINGPhase 2

IVIG Trial for the Treatment of Bronchopulmonary Dysplasia

NCT06925360 · Bronchopulmonary Dysplasia

Lumbar Drainage of Intraventricular Hemorrhage

NCT06510842 · Intraventricular Hemorrhage, Lumbar Drainage, and more

RAINBOW-ICH Trial of AI Guided Minimally Invasive Neurosurgery for ICH

NCT07205263 · Basal Ganglia Hemorrhage, Intraventricular Hemorrhage, and more

RECRUITINGPhase 2

Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT

NCT07143201 · Patent Ductus Arteriosus, Preterm

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 6, 2019Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment237

Start dateJul 2017

Last updatedSep 6, 2019

Condition

Bronchopulmonary Dysplasia Patent Ductus Arteriosus Intraventricular Hemorrhage Necrotizing Enterocolitis Periventricular Leukomalacia

Locations shown

Peking University Third Hospital

Beijing

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 6, 2019Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions